VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $34,899,000 | +9.1% | 243,863 | 0.0% | 9.08% | +11.2% |
| Q3 2014 | $31,995,000 | +13.8% | 243,863 | +9.4% | 8.17% | +13.9% |
| Q2 2014 | $28,111,000 | +97.6% | 222,890 | +106.6% | 7.17% | +94.6% |
| Q1 2014 | $14,223,000 | -16.0% | 107,890 | -25.2% | 3.68% | -6.5% |
| Q4 2013 | $16,940,000 | +7.3% | 144,295 | -4.6% | 3.94% | -3.6% |
| Q3 2013 | $15,785,000 | +21.2% | 151,295 | 0.0% | 4.09% | +15.0% |
| Q2 2013 | $13,023,000 | – | 151,295 | – | 3.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |